<DOC>
	<DOCNO>NCT02761187</DOCNO>
	<brief_summary>The purpose study describe contemporary , real-world disease participant presentation , therapy , clinical outcome participant newly diagnose yet relapse [ ND ] multiple myeloma ( MM ) , participant relapsed/refractory [ R/R ] MM .</brief_summary>
	<brief_title>An Observational Study Presentation , Treatment Patterns , Outcomes Multiple Myeloma Participants</brief_title>
	<detailed_description>This non-interventional , observational . This study look contemporary , real-world presentation , therapy , clinical outcome participant MM . Participants ask change routine clinical treatment . Participants complete patient self-reported outcome ( PROs ) survey home routine visit . The study enroll approximately 5000 participant . Participants assign one follow cohort base upon diagnosis MM : - ND MM - R/R MM This multi-center trial conduct worldwide . The overall time participate study 5 year . Participants evaluate followed-up period least 5 year , death , end study , whichever come first .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<criteria>Is 18 year age old . Is newly diagnose yet relapse MM document month year diagnosis , criterion meet diagnosis , stage , MMdirected treatment history , include duration , Has relapsed/refractory MM document data medical record regard diagnosis ( month year ) , prior exposure class medication ( example , proteosome inhibitor , immunomodulatory drug ) , number previous line therapy . Is willing able sign inform consent participate . Is willing able complete patient assessment questionnaire . Is report site study second opinion ( consultation ) participant whose frequency consult followup adequate quarterly electronic case report form ( eCRF ) completion . Has participate another study ( observational interventional ) prohibit participation study . Is unable unwilling complete health relate quality life ( HRQoL ) Patient selfreported outcomes ( PROs ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Drug Therapy</keyword>
</DOC>